Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer.

Hitt R, López-Pousa A, Martínez-Trufero J, Escrig V, Carles J, Rizo A, Isla D, Vega ME, Martí JL, Lobo F, Pastor P, Valentí V, Belón J, Sánchez MA, Chaib C, Pallarés C, Antón A, Cervantes A, Paz-Ares L, Cortés-Funes H.

J Clin Oncol. 2005 Dec 1;23(34):8636-45. Epub 2005 Nov 7. Erratum in: J Clin Oncol. 2006 Feb 20;24(6):1015.

PMID:
16275937
2.

Variabilin: a dual inhibitor of human secretory and cytosolic phospholipase A2 with anti-inflammatory activity.

Escrig V, Ubeda A, Ferrandiz ML, Darias J, Sanchez JM, Alcaraz MJ, Paya M.

J Pharmacol Exp Ther. 1997 Jul;282(1):123-31.

PMID:
9223548
3.

[Effect of treatment with 13-cis-retinoic acid and ara-C on the hematopoietic stem cells of patients with myelodysplastic syndromes].

García Marco J, Miguel Sosa A, García Conde J, Miguel García A, Arbona C, Escrig V, Benet I, Navarro I, Ruiz A, Carbonell F.

Sangre (Barc). 1994 Aug;39(4):241-4. Spanish.

PMID:
7985051
4.

[A pulmonary mycotic sequestrum during invasive aspergillosis].

Chiner E, Arbona C, Pérez D, Escrig V, García-Conde J, Marín J.

An Med Interna. 1990 Jun;7(6):304-6. Spanish.

PMID:
2129388
5.

[Conventional and aggressive chemo-radiotherapy of chronic granulocytic leukemia in its different phases. Other therapeutic problems].

Garciá-Conde J, Alberola V, Lluch A, Escrig V.

Sangre (Barc). 1984;29(4-B):577-97. Review. Spanish. No abstract available.

PMID:
6393383

Supplemental Content

Loading ...
Support Center